Pharmacodynamics and pharmacokinetics of ciprofloxacin during sustained low-efficiency dialysis
Critical Care volume 18, Article number: P402 (2014)
Little information is available regarding ciprofloxacin pharmacokinetics and pharmacodynamics in sepsis patients receiving sustained low-efficiency dialysis (SLED). This study determined the pharmacokinetics and simulated pharmacodynamics of ciprofloxacin in ICU patients during SLED.
This study was a prospective evaluation of ciprofloxacin pharmacokinetics in patients with sepsis and >18 years of age, urine output <200 ml/day and receiving SLED for at least 8 hours. Following informed consent, plasma samples were collected at baseline and 1, 2, 4, and 8 hours after a ciprofloxacin 400 mg dose i.v. during SLED and post-SLED therapy at the same times. Dialysate samples were collected at 4-hour intervals during SLED. Pharmacokinetic parameters were determined using WinNonlin and compared between the two periods. Simulated pharmacodynamic parameters were determined for Pseudomonas aeruginosa using MIC = 2.
A total of seven patients (four male, three female, age 56.9 ± 7.6, APACHE II 26.8 ± 2.4) were enrolled. Ciprofloxacin was cleared relatively rapidly with a half-life of 6.9 hours and a Ke of 0.108/hour during SLED compared with 11.9 hours and 0.057/hour post-SLED (P < 0.05). Simulated pharmacodynamics demonstrated inadequate coverage for P. aeruginosa during sLeD with Cmax/MIC ratio 5.7 ± 1.2 and AUC/MIC 77.5 ± 22.3.
Ciprofloxacin is rapidly cleared during SLED similar to clearance during normal renal function, which may result in adequate pharmacodynamic coverage for some pathogens.
About this article
Cite this article
Olsen, K., Plumb, T., Reardon, N. et al. Pharmacodynamics and pharmacokinetics of ciprofloxacin during sustained low-efficiency dialysis. Crit Care 18 (Suppl 1), P402 (2014). https://doi.org/10.1186/cc13592